Isuzinaxib hydrochloride | Interleukin Related interleukin-related.com

Product Name :
Isuzinaxib hydrochloride

Search keywords :
APX-115

drugId :
null

Target Vo:
NADPH oxidase

Target Vo Short Name :
NOX

Moa_Name:
NADPH oxidase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Ewha Woman’S University

Active Company_Name :
Aptabio Therapeutics Inc

Active Indication_Name:
Catheter-Related Infections

In Active Indication_Name:
Coronavirus Disease 2019 (COVID-19)

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
ERCC1 Antibody (YA770)
TBK1 Antibody (YA040)
IKK beta Antibody: IKK beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 87 kDa, targeting to IKK beta. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts